FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063257 [Registered on: 28/02/2024] Trial Registered Prospectively
Last Modified On: 23/02/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Safety]  
Study Design  Single Arm Study 
Public Title of Study   Safety assessment of products on skin 
Scientific Title of Study   Clinical Evaluation of irritation potential of Hair Care formulation on healthy human subjects 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
D01-6Q27-DX-OR23; Version: 01; Dated: 13/02/2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel, Mumbai.

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel, Mumbai.


MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel, Mumbai.

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  mohit.CTRI@gmail.com  
 
Source of Monetary or Material Support  
Dabur International Limited, Naturelle LLC, Emirates Link Road AL Jazira Al Hamra Industrial Area POBox: 6399, Ras Al Khaimah U.A.E 
 
Primary Sponsor  
Name  Dabur International Limited 
Address  Naturelle LLC, Emirates Link Road AL Jazira Al Hamra Industrial Area POBox: 6399, Ras Al Khaimah U.A.E 
Type of Sponsor  Other [FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil  Mascot Spincontrol India Pvt. Ltd.   Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel, Mumbai
Mumbai
MAHARASHTRA 
02243349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Normal skin 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Negative Control (0.9% Isotonic saline solution)  40 microliters of 0.9% Isotonic saline solution is dispensed on aluminium finn chambers and then be taped onto the back of subjects at T0 visit. This is a single application and the occluded patch is removed after 24 hours.  
Comparator Agent  Positive Control (1% w/w SLS)   40 microliters of 1% w/w Sodium Lauryl Sulphate isdispensed on aluminium finn chambers and then be taped onto the back of subjects at T0 visit. This is a single application and the occluded patch is removed after 24 hours.  
Intervention  Vatika Henna HAIR COLOUR Henna & Almond (EPV30044)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
Intervention  Vatika Henna HAIR COLOUR Henna & Blackseed (EPV30118)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
Intervention  Vatika Henna HAIR COLOUR Henna & Blueberry (EPV20014)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
Intervention  Vatika Henna HAIR COLOUR Henna & Coffee (EPV30036)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes.  
Intervention  Vatika Henna HAIR COLOUR Henna & Karkade (EPV30012)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
Intervention  Vatika Henna HAIR COLOUR Henna & Plum (EPV30005)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
Intervention  Vatika Henna HAIR COLOUR Henna & Walnut (EPV30002)  1:4 solution of the investigational product is prepared in distilled water. 0.04 ml of test samples is applied on the previously marked area of 3 x 3 cm2 on the inner upper arm. This is a single application, and the product is removed after 30 minutes. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Asian Indian male and female subjects
2) Healthy human subjects (no infectious and evolutive pathology which could make the
subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up)
3) Between 18 and 65 years of age
4) Skin is healthy on the studied anatomic unit (free of eczema,wounds, inflammatory scar….)
5)subjects who show no allergic / irritation symptoms to the test product at skin sensitivity test will be enrolled in the study. 
 
ExclusionCriteria 
Details  1 For female: Being pregnant or breastfeeding or having stopped to
breastfeed in the past three months
2 Having refused to give his/her assent by not signing the consent
form
3 Taking part in another study liable to interfere with this study
4 Being diabetic.
5 Being asthmatic.
6 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the
only medication permitted is paracetamol).
7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Dermatological safety / Irritation potential on skin   Baseline,0 hrs,24 hrs and 7 days 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  NA 
 
Target Sample Size   Total Sample Size="26"
Sample Size from India="26" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="8" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: The objective of this clinical study will be to evaluate the irritation potential on healthy human subjects of Hair Care Formulations. 

 

Duration of study: 8 days study 

 

Kinetics: T-2 day(sensitivity test), T0 (Evaluation of test sites by Dermatologist, Patch application) ,T1(Patch removal, Evaluation of test sites by Dermatologist ,T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases) 

 

Population: 26 healthy subjects (13 males + 13 females). 

 

 The test area is checked for erythema and oedema caused due to the product and compared with positive control

 


 
Close